Rongtao Medical Publishes Framework for Managing Legacy Ultrasound Cybersecurity
Guangzhou Rongtao Medical Technology Co., Ltd. published an evidence-based framework on August 27, 2026, to help healthcare providers decide whether to patch, segment, isolate, or replace legacy ultrasound systems. The strategy draws on Food and Drug Administration clearance records, Cybersecurity and Infrastructure Security Agency advisories, adverse-event data, and OEM support notices to address aging medical fleets.
Decoding the Five-Clock Lifecycle of Legacy Medical Imaging
Age alone is a poor indicator for retiring diagnostic imaging equipment, according to the newly released Rongtao Medical report. Instead, the framework evaluates equipment health across five distinct operational clocks that expire at staggered intervals: clinical usefulness, original equipment manufacturer product support, software and component support, security-control supportability, and physical serviceability. When software updates stop, physical hardware may still have years of functional life remaining.
“The most useful sentence in the whole record comes from an OEM end-of-support letter that stopped a product’s software clock and kept its hardware clock running in the same document,” said Frank Zhu, general manager of Rongtao Medical, in a company release. “That is the reality of legacy fleets: the clocks are separable. When the software clock stops, somebody still has to keep the hardware running — and that is the lane independent service occupies, inside the disposition framework, never as a substitute for it.”
The framework establishes four distinct pathways for managing equipment: patching, network segmentation, physical isolation, or complete replacement. Each pathway requires specific evidence gates and stop conditions. Crucially, the guidance clarifies that independent hardware service does not replace cybersecurity measures. A physical repair cannot generate a software patch, validate an operating system change, or independently secure a networked device against digital threats.
Regulatory Gaps and the Pre-Statute Ultrasound Fleet
According to an analysis of all 2,066 FDA 510(k) clearances for cart and console ultrasound systems issued between 1977 and mid-2026, 90.1 percent of designs cleared the regulatory hurdle before Section 524B’s cyber-device requirements took effect on March 29, 2023. More critically, every single console cleared between 2006 and 2020—the exact vintage band that dominates working fleets—predates the statute entirely.
With annual clearance volumes holding flat between 55 and 83 systems a year, this pre-statute population will not age out on any planning horizon. Regulatory safety records offer little immediate clarity. Data shows that zero of the 8,525 ultrasound adverse-event reports filed with the FDA since 2019 mention ransomware, malware, cybersecurity, hacking or a virus. The FDA recall database lists only a single ultrasound cybersecurity recall, originating back in 2008. The report notes that this silence reflects a reporting pathway rather than a risk level, leaving healthcare administrators to make decisions without waiting for a safety signal.
Compounding the challenge, federal vulnerability trackers operate on timelines that clinical devices struggle to meet. The federal Known Exploited Vulnerabilities catalog enforces a 21-day median remediation clock that no validated medical device can meet. Furthermore, the catalog lists no diagnostic-imaging manufacturer among its 276 vendors, underscoring a disconnect between standard IT patch management and clinical engineering realities.
Advisory Shortfalls and Practical Service Realities
Public advisory records reinforce the necessity of dispositions beyond routine patching. An examination of 18 individually verified CISA medical advisories affecting imaging products reveals that half left at least one named product with no software fix available at publication. All four advisories specifically naming ultrasound product lines featured incomplete patch coverage, forcing reliance on alternative remedies such as network restriction, physical access controls, or replacement.

To support facilities navigating these complex asset management decisions, Rongtao Medical maintains an extensive infrastructure through its technical and warehousing center in Guangzhou, China. The 3,000-square-meter facility is ISO 13485:2016 and ISO 9001:2015 certified and employs over 35 senior engineers. The center holds an inventory of hundreds of ultrasound systems and more than 3,000 replacement parts spanning major manufacturers including GE Healthcare, Philips, Siemens, Hitachi, Mindray, Samsung Medison, Toshiba (Canon), Aloka, and Biosound Esaote.

“For distributors, downtime on an ultrasound system means lost hospital revenue and pressure on the service contract,” Frank Zhu notes. “Partners want one vendor who can handle any OEM board on the bench, deliver predictable turnaround, and prove the work before the customer asks.”
Standardized quality control requires a strict 48-hour real-machine testing protocol on all repaired boards before they leave the facility. Deep component reserves enable technicians to resolve common faults—such as those on RF modules, acquisition boards, receive beamformers, power-supply assemblies, and control panels—without relying on third-party sourcing. Standard turnaround times range from five to eight business days, with global logistics coordinated via carriers like DHL, FedEx, and UPS.